The Clorox Company (CLX)

Financial leverage ratio

Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Total assets US$ in thousands 5,751,000 5,805,000 5,908,000 5,991,000 5,945,000 5,818,000 6,045,000 6,153,000 6,158,000 6,322,000 6,190,000 6,274,000 6,334,000 6,441,000 6,855,000 6,777,000 6,213,000 5,850,000 5,459,000 5,397,000
Total stockholders’ equity US$ in thousands 328,000 91,000 53,000 -37,000 220,000 3,000 321,000 326,000 556,000 400,000 313,000 368,000 411,000 743,000 1,184,000 1,115,000 908,000 695,000 555,000 550,000
Financial leverage ratio 17.53 63.79 111.47 27.02 1,939.33 18.83 18.87 11.08 15.80 19.78 17.05 15.41 8.67 5.79 6.08 6.84 8.42 9.84 9.81

June 30, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $5,751,000K ÷ $328,000K
= 17.53

The financial leverage ratio measures the extent to which a company relies on debt to finance its operations and growth. Looking at the data provided for The Clorox Company, we can see significant fluctuations in the financial leverage ratio over the past few quarters.

The financial leverage ratio for The Clorox Company has shown a wide range of values, with a peak of 1,939.33 in the first quarter of 2023, indicating an exceptionally high level of debt relative to equity at that time. This could be due to unusual circumstances such as significant debt taken on for a specific purpose or a temporary distortion in the financials.

Subsequently, the financial leverage ratio decreased substantially in the following quarters, suggesting a reduction in the company's debt relative to its equity. However, the ratio remained relatively high compared to historical levels in some quarters, such as December 2023 and March 2024.

The fluctuations in The Clorox Company's financial leverage ratio may indicate changing capital structure decisions, such as borrowing to fund investments or paying down debt to reduce financial risk. It is essential for investors and analysts to delve deeper into the company's financial statements and disclosures to understand the reasons behind these variations and assess the implications for the company's financial health and risk profile.